Ketamine in Severe Traumatic Brain Injury

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

November 30, 2026

Conditions

Traumatic Brain InjuryTraumatic Encephalopathy

Interventions

DRUG

Ketamine Hydrochloride

Administration of ketamine with subsequent measurement of intracranial pressure and brain tissue oxygenation

Trial Locations (2)

RECRUITING

Parkland Memorial Hospital, Dallas

RECRUITING

Parkland Memorial Hospital, Dallas

All Listed Sponsors

lead

University of Texas Southwestern Medical Center

OTHER

NCT06062628 - Ketamine in Severe Traumatic Brain Injury | Biotech Hunter | Biotech Hunter